Elixinol Share Price Down: Two Thoughts on its Future
After going to almost $6 a share, it is going for almost a tenth of this price today. We look at what has happened to the Elixinol share price and the company’s restructure.
ASX:EXL
Why ASX Cannabis Stocks are Down — Should You Invest?
It’s been a tough year for ASX cannabis stocks with many companies shedding value over a 12-month window. Only Althea has emerged from the last year with a gain to show for it. It’s worth taking a look at the ETFMG Alternative Harvest ETF chart to see what’s happening to cannabis stocks globally....
Elixinol Share Price Up as US Warms to Cannabis (ASX: EXL)
Cannabis and hemp are back in the US headlines. And one local pot stock — Elixinol — is feeling a high…share price. At time of writing Elixinol Global Ltd [ASX:EXL] is up 11%. Though it did peak even higher at a 12.28% gain prior in early trading...
ASX Cannabis Stocks Wrap: MGC, BDA Elixinol News
Today, we look at the latest Elixinol news, along with recent announcements out of MGC and BOD. We conclude that Elixinol could encounter support in the coming weeks or months. Meanwhile, MGC and BOD remain exciting but more speculative cannabis plays.
A Look at the MGC Pharmaceuticals Share Price
At time of writing, the share price of MGC Pharmaceuticals Ltd [ASX:MXC] is holding steady at 5.3 cents. The company spiked in late in 2017, along with other ASX-listed cannabis companies...
Elixinol Share Price up on Quarterly: But Is Its Growth Slowing?
At time of writing, the share price of Elixinol Global Limited [ASX:EXL] is up 1.45% trading at $3.50.The Elixinol share price registered a small gain today after four straight losing sessions
Elixinol Share Price Barely Budges on Licence: An Explanation
Today, the Elixinol share price was trading down initially but was able to register a small uptick when the announcement was released, and then settled where it started at $4.As per the announcement, the Manufacture licence allows Elixinol’s subsidiary to manufacture...
New German Deal Sends Elixinol’s Share Price 5.86% Higher
Elixinol has focused much of its operational efforts to rapid global expansion over the past couple of years. In 2019 alone, the company has managed to expand operations across Europe, including the Netherlands, Spain and United Kingdom (a cannabis market predicted to be worth €115.7 billion by 2028). It entered the New Zealand market and significantly expanded US operations via capital raisings and acquisitions.
Is Elixinol Share Price a Buy after Institutional Placement?
In an announcement made this morning, EXL said it will issue approximately 12.8 million shares at $3.90 per share, representing an 8.7% discount to the closing price on Monday. We look at Elixinol's prospects going forward.
Elixinol Global Share Price Down after Land Purchase Announcement
At time of writing, Elixinol Global Limited [ASX:EXL] is down 2.43%, trading at $3.21. The latest news out of the company is that it has purchased new land for its proposed manufacturing facility and renamed its Australian medical cannabis company.